Fundraising Fox
/Companies
Sign in

Ignyta

San Diego, US · Founded 2011 · Delaware corporation · 1 known investors

Find your way into Ignyta

Sign up to see every warm intro you have to Ignyta

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ignyta team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Precision oncology company developing targeted therapeutics with companion diagnostics; IPO'd in 2014, acquired by Roche in 2018.

Biotech

Founders & leadership

Ignyta was founded in 2011 by Jonathan E. Lim, M.D..

JE
Jonathan E. Lim, M.D.President and Chief Executive Officer
VH
Valerie Harding, Ph.D.Senior Vice President, Chemistry, Manufacturing and Controls
BP
Bernard ParkerChief Commercial Officer
ZH
Zachary HornbyChief Operating Officer
IP
Igor P. Bilinsky, Ph.D.Executive
MO
Matt Onaitis, J.D.Secretary and General Counsel
RWRobert Wild, Ph.D.
Robert Wild, Ph.D.Chief Scientific Officer and SVP, Research
JFJames Freddo, M.D.
James Freddo, M.D.ExecutiveDr. James Freddo is Director at Ignyta and brings over 25 years of pharmaceutical development experience, including work on clinical programs for biologics and small molecules across all phases from first-in-human through registration. He has served on the boards of public companies and scientific advisory boards, and has performed due diligence and regulatory strategy work for investors and biotech organizations.
JC
Jacob Chacko, M.D.Chief Financial Officer

Board

AC
Alex CasdinBoard director
JBJames Bristol, Ph.D.
James Bristol, Ph.D.Board director
HD
Heiner Dreismann, Ph.D.Board director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$30M disclosed across 1 round · 2015

▶$30MraisedNov 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Valerie Harding, Ph.D.Executive Officer
  • Bernard ParkerExecutive Officer
  • Zachary HornbyExecutive Officer
  • Igor P. Bilinsky, Ph.D.Executive Officer
  • Matt Onaitis, J.D.Executive Officer
  • Robert Wild, Ph.D.Executive Officer
  • James Freddo, M.D.Director
  • Jonathan E. Lim, M.D.Executive Officer, Director
  • Jacob Chacko, M.D.Executive Officer
  • Alex CasdinDirector
  • James Bristol, Ph.D.Director
  • Heiner Dreismann, Ph.D.Director
  • Pratik S. Multani, M.D.Executive Officer
Offering amount
$39M
Amount sold
$30M
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Ignyta do?
Precision oncology company developing targeted therapeutics with companion diagnostics; IPO'd in 2014, acquired by Roche in 2018.
Who founded Ignyta?
Ignyta was founded by Jonathan E. Lim, M.D. in 2011.
Who are Ignyta's investors?
Ignyta's investors include Frazier Life Sciences.
How much funding has Ignyta raised?
Ignyta has disclosed $30M raised across 1 round.
Where is Ignyta headquartered?
Ignyta is headquartered in San Diego, US.